ArticleInfectious diseases of poverty2014
Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements.
Article in Infectious diseases of poverty, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Naturally occurring phenylethanoids and phenylpropanoids: antimalarial potential.RSC advances · 2023Article
- Taking a re-look at cap-binding signatures of the mRNA cap-binding protein eIF4E orthologues in trypanosomatids.Molecular and cellular biochemistry · 2021Review
- Alsinol, an arylamino alcohol derivative active against Plasmodium, Babesia, Trypanosoma, and Leishmania: past and new outcomes.Parasitology research · 2020Article
- Preparedness for Chagas disease spreading worldwide.Infectious diseases of poverty · 2020Article
- Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis.Parasitology · 2018Review
- Humanized Mice Are Instrumental to the Study ofFrontiers in immunology · 2018Review
- Infectious Diseases of Poverty, the first five years.Infectious diseases of poverty · 2017Article
- Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria.Infectious diseases of poverty · 2017Article
- Major parasitic diseases of poverty in mainland China: perspectives for better control.Infectious diseases of poverty · 2016Review
- Comparative evaluation of the diagnosis, reporting and investigation of malaria cases in China, 2005-2014: transition from control to elimination for the national malaria programme.Infectious diseases of poverty · 2016Article
- Occupational Hazards in the Thai Healthcare Sector.New solutions : a journal of environmental and occupational health policy : NS · 2016Article
- Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.Infectious diseases of poverty · 2016Article
- Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.Frontiers in immunology · 2016Article
- China's 1-3-7 surveillance and response strategy for malaria elimination: Is case reporting, investigation and foci response happening according to plan?Infectious diseases of poverty · 2015Article
- Mining geographic variations of Plasmodium vivax for active surveillance: a case study in China.Malaria journal · 2015Article
- Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Clinical microbiology reviews · 2014Review
- Surveillance-response systems: the key to elimination of tropical diseases.Infectious diseases of poverty · 2014Article
- China-Africa cooperation initiatives in malaria control and elimination.Advances in parasitology · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vector-borne protozoan diseases represent a serious public health challenge, especially in the tropics where poverty together with vector-favorable climates are the aggravating factors. Each of the various strategies currently employed to face these scourges is seriously inadequate. Despite enormous efforts, vaccines-which represent the ideal weapon against these parasitic diseases-are yet to be sufficiently developed and implemented. Chemotherapy and vector control are therefore the sole effective attempts to minimize the disease burden. Nowadays, both strategies are also highly challenged by the phenomenon of drug and insecticide resistance, which affects virtually all interventions currently used. The recently growing support from international organizations and governments of some endemic countries is warmly welcome, and should be optimally exploited in the various approaches to drug and insecticide research and development to overcome the burden of these prevalent diseases, especially malaria, leishmaniasis, Human African Trypanosomiasis (HAT), and Chagas disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.